Cargando…
Association between COX-2 gene polymorphisms and risk of hepatocellular carcinoma development: a meta-analysis
OBJECTIVE: To investigate the association between cyclo-oxygenase-2 (COX-2) polymorphism and the risk of hepatocellular carcinoma (HCC) development. DESIGN: Systematic review and meta-analysis of COX-2 polymorphism and risk of HCC development among people with or without HCC. DATA SOURCES: EMBASE, P...
Autores principales: | Lu, Si-Cong, Zhong, Jian-Hong, Tan, Jun-Tao, Tang, Hua-Lin, Liu, Xiao-Guang, Xiang, Bang-De, Li, Le-Qun, Peng, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606424/ https://www.ncbi.nlm.nih.gov/pubmed/26438136 http://dx.doi.org/10.1136/bmjopen-2015-008263 |
Ejemplares similares
-
Risk factors for malignant transformation of hepatocellular adenoma to hepatocellular carcinoma: protocol for systematic review and meta-analysis
por: Thevathasan, Tharusan, et al.
Publicado: (2021) -
Epigenetic identification of mitogen-activated protein kinase 10 as a functional tumor suppressor and clinical significance for hepatocellular carcinoma
por: Tang, Liping, et al.
Publicado: (2021) -
Low Psoas-Muscle index is associated with decreased survival in hepatocellular carcinoma treated with transarterial chemoembolization
por: Zhang, Jin-Xing, et al.
Publicado: (2022) -
Antiviral therapy for prevention of hepatocellular carcinoma and mortality in chronic hepatitis B: systematic review and meta-analysis
por: Thiele, Maja, et al.
Publicado: (2013) -
Glasgow Prognostic Score and modified Glasgow Prognostic Score and survival in patients with hepatocellular carcinoma: a meta-analysis
por: Lu, Lingling, et al.
Publicado: (2021)